Cure Pharmaceutical Holding Corp. CFO Michael Redard receives $1.0M in 2019
Cure Pharmaceutical Holding Corp. reports 2019 executive compensation
By ExecPay News
Published: August 7, 2020
Cure Pharmaceutical Holding Corp. reported fiscal year 2019 executive compensation information on August 7, 2020.
In 2019, four executives at Cure Pharmaceutical Holding Corp. received on average a compensation package of $569.8K, a 54% increase compared to previous year.
Michael Redard, Chief Financial Officer, received $1M in total. 89.64% of Redard's compensation, or $925.3K, was in option awards. Redard also received $106.9K in salary.
Robert Davidson, Chief Executive Officer, received a compensation package of $932.7K, which increased by 100% compared to previous year. 78.91% of the compensation package, or $736K, was in option awards.
Jessica Rousset, Chief Operating Officer, earned $180K in 2019, a 59% decrease compared to previous year.
Mark Udell, Chief Accounting Officer, received $134.4K in 2019, which decreases by 34% compared to 2018.